NASDAQ : INAB
IN8bio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.9801 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 9.66M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 9.34M | 9.65M | 12.64M | 13.51M | 14.46M | 7.31M |
| Research & Development | 9.86M | 10.21M | 16.96M | 16.83M | 14.06M | 7.35M |
| Operating Expenses | 19.20M | 19.86M | 29.60M | 30.34M | 28.52M | 14.65M |
| Operating Income | -19.20M | -19.86M | -29.60M | -30.34M | -28.52M | -14.65M |
| Interest & Investment Income | 534.00K | 421.00K | 230.00K | |||
| Other Non Operating Income (Expenses) | 330.00K | |||||
| EBT Excluding Unusual Items | -18.67M | -19.44M | -29.37M | -30.01M | -28.52M | -14.65M |
| Merger & Restructuring Charges | -1.07M | |||||
| Pretax Income | -18.67M | -19.44M | -30.44M | -30.01M | -28.52M | -14.65M |
| Net Income | -18.67M | -19.44M | -30.44M | -30.01M | -28.52M | -14.65M |
| Net Income to Common | -18.67M | -19.44M | -30.44M | -30.01M | -28.52M | -14.65M |
| Shares Outstanding (Basic) | 12.65M | 4.37M | 1.78M | 995.50K | 698.93K | 332.32K |
| Shares Outstanding (Diluted) | 12.65M | 4.37M | 1.78M | 995.50K | 698.93K | 332.32K |
| EPS (Basic) | -1.48 | -4.44 | -17.05 | -30.14 | -40.81 | -44.09 |
| EPS (Diluted) | -1.48 | -4.44 | -17.05 | -30.14 | -40.81 | -44.09 |
| Free Cash Flow | -14.60M | -12.71M | -24.34M | -23.94M | -27.83M | -13.82M |
| Free Cash Flow Per Share | -1.15 | -2.91 | -13.63 | -24.05 | -39.81 | -41.58 |
| EBITDA | -17.80M | -18.09M | -27.76M | -28.50M | -27.91M | -14.03M |
| D&A For EBITDA | 1.40M | 1.77M | 1.83M | 1.83M | 608.00K | 626.00K |
| EBIT | -19.20M | -19.86M | -29.60M | -30.34M | -28.52M | -14.65M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 17.96M | 27.09M | 11.12M | 21.28M | 18.18M | 37.02M |
| Cash & Short-Term Investments | 17.96M | 27.09M | 11.12M | 21.28M | 18.18M | 37.02M |
| Prepaid Expenses | 176.00K | 529.00K | 710.00K | 3.07M | 3.82M | 1.91M |
| Other Current Assets | 364.00K | 259.00K | 748.00K | 270.00K | 232.00K | 52.00K |
| Total Current Assets | 18.50M | 27.88M | 12.58M | 24.62M | 22.23M | 38.98M |
| Property, Plant & Equipment | 2.97M | 4.04M | 7.83M | 8.57M | 10.30M | 2.83M |
| Other Long-Term Assets | 278.00K | 366.00K | 541.00K | 511.00K | 507.00K | 409.00K |
| Total Assets | 21.75M | 32.28M | 20.94M | 33.71M | 33.04M | 42.22M |
| Accounts Payable | 444.00K | 309.00K | 389.00K | 924.00K | 2.09M | 395.00K |
| Accrued Expenses | 761.00K | 1.63M | 1.05M | 2.96M | 2.34M | 1.24M |
| Current Portion of Leases | 1.05M | 1.22M | 1.65M | 1.51M | 1.39M | 626.00K |
| Total Current Liabilities | 2.25M | 3.16M | 3.08M | 5.39M | 5.82M | 2.26M |
| Long-Term Leases | 1.13M | 1.56M | 3.38M | 3.38M | 4.49M | 1.78M |
| Total Liabilities | 3.38M | 4.72M | 6.47M | 8.77M | 10.31M | 4.04M |
| Common Stock | 10.00K | 10.00K | 7.00K | 4.00K | 3.00K | 2.00K |
| Additional Paid-In Capital | 169.32M | 168.64M | 136.13M | 116.15M | 83.94M | 70.87M |
| Retained Earnings | -150.97M | -141.10M | -121.66M | -91.22M | -61.21M | -32.69M |
| Total Common Equity | 18.36M | 27.56M | 14.48M | 24.94M | 22.73M | 38.18M |
| Shareholders' Equity | 18.36M | 27.56M | 14.48M | 24.94M | 22.73M | 38.18M |
| Total Liabilities & Equity | 21.75M | 32.28M | 20.94M | 33.71M | 33.04M | 42.22M |
| Total Debt | 2.18M | 2.78M | 5.03M | 4.89M | 5.87M | 2.41M |
| Net Cash (Debt) | 15.78M | 24.31M | 6.09M | 16.39M | 12.31M | 34.61M |
| Net Cash Per Share | 1.25 | 5.56 | 3.41 | 16.46 | 17.61 | 104.15 |
| Filing Date Shares Outstanding | 9.86M | 9.85M | 2.71M | 1.44M | 831.27K | 627.08K |
| Total Common Shares Outstanding | 9.85M | 9.77M | 2.42M | 1.44M | 818.17K | 626.04K |
| Working Capital | 16.24M | 24.72M | 9.49M | 19.23M | 16.41M | 36.72M |
| Book Value Per Share | 1.86 | 2.82 | 5.99 | 17.28 | 27.78 | 60.99 |
| Tangible Book Value | 18.36M | 27.56M | 14.48M | 24.94M | 22.73M | 38.18M |
| Tangible Book Value Per Share | 1.86 | 2.82 | 5.99 | 17.28 | 27.78 | 60.99 |
| Machinery | 1.03M | 787.00K | 851.00K | 749.00K | 693.00K | 443.00K |
| Construction In Progress | 182.00K | 29.00K | 403.00K | |||
| Leasehold Improvements | 3.92M | 3.92M | 3.92M | 3.92M | 3.90M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -18.67M | -19.44M | -30.44M | -30.01M | -28.52M | -14.65M |
| Depreciation & Amortization | 2.00M | 2.50M | 2.65M | 2.50M | 1.10M | 788.00K |
| Loss (Gain) From Sale of Assets | 45.00K | |||||
| Stock-Based Compensation | 2.16M | 3.19M | 5.00M | 4.37M | 3.47M | 2.19M |
| Change in Accounts Payable | 65.00K | -80.00K | -535.00K | -981.00K | 1.51M | -319.00K |
| Change in Other Net Operating Assets | 86.00K | 1.12M | -877.00K | 777.00K | -1.68M | -1.52M |
| Operating Cash Flow | -14.36M | -12.71M | -24.15M | -23.34M | -24.12M | -13.51M |
| Capital Expenditures | -242.00K | -187.00K | -600.00K | -3.71M | -309.00K | |
| Investing Cash Flow | -242.00K | -187.00K | -600.00K | -3.71M | -309.00K | |
| Long-Term Debt Repaid | -693.00K | -794.00K | -798.00K | -615.00K | -709.00K | |
| Net Debt Issued (Repaid) | -403.00K | -693.00K | -794.00K | -798.00K | -615.00K | -709.00K |
| Issuance of Common Stock | 19.71M | 29.33M | 15.07M | 27.84M | 9.60M | 36.36M |
| Other Financing Activities | -77.00K | -89.00K | -2.69M | |||
| Financing Cash Flow | 19.23M | 28.64M | 14.18M | 27.04M | 8.99M | 32.95M |
| Net Cash Flow | 4.63M | 15.93M | -10.15M | 3.10M | -18.84M | 19.14M |
| Free Cash Flow | -14.60M | -12.71M | -24.34M | -23.94M | -27.83M | -13.82M |
| Free Cash Flow Per Share | -1.15 | -2.91 | -13.63 | -24.05 | -39.81 | -41.58 |
| Levered Free Cash Flow | -7.92M | -5.55M | -12.36M | -12.53M | -16.25M | -9.06M |
| Unlevered Free Cash Flow | -7.92M | -5.55M | -12.36M | -12.53M | -16.25M | -9.06M |
| Change in Working Capital | 151.00K | 1.04M | -1.41M | -204.00K | -170.00K | -1.84M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 8.89M | 22.84M | 18.64M | 59.67M | 56.60M | 82.33M |
| Enterprise Value | -6.89M | 15.11M | 20.11M | 52.08M | 33.79M | 44.22M |
| Last Close Price | 0.90 | 2.34 | 7.72 | 41.40 | 69.30 | 131.70 |
| PB Ratio | 0.48 | 0.83 | 1.29 | 2.39 | 2.49 | 2.16 |
| P/TBV Ratio | 0.48 | 0.83 | 1.29 | 2.39 | 2.49 | 2.16 |
| Debt / Equity Ratio | 0.12 | 0.10 | 0.35 | 0.20 | 0.26 | 0.06 |
| Net Debt / Equity Ratio | -0.86 | -0.88 | -0.42 | -0.66 | -0.54 | -0.91 |
| Net Debt / EBITDA Ratio | 0.89 | 1.34 | 0.22 | 0.57 | 0.44 | 2.47 |
| Net Debt / FCF Ratio | 1.08 | 1.91 | 0.25 | 0.69 | 0.44 | 2.50 |
| Quick Ratio | 7.97 | 8.57 | 3.61 | 3.95 | 3.12 | 16.41 |
| Current Ratio | 8.21 | 8.82 | 4.08 | 4.57 | 3.82 | 17.28 |
| Return on Equity (ROE) | -111.11% | -92.49% | -154.44% | -125.90% | -93.64% | -51.87% |
| Return on Assets (ROA) | -58.37% | -46.64% | -67.70% | -56.81% | -47.37% | -29.01% |
| Return on Capital Employed (ROCE) | -98.50% | -68.20% | -165.70% | -107.10% | -104.80% | -36.70% |
| Earnings Yield | -163.75% | -85.11% | -163.26% | -50.29% | -50.39% | -17.80% |
| FCF Yield | -164.28% | -55.65% | -130.54% | -40.12% | -49.16% | -16.78% |
| Buyback Yield / Dilution | -405.25% | -145.07% | -79.30% | -42.43% | -110.32% | -191.59% |